New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 24, 2013
11:50 EDTEXELExelixis announces availability of COMETRIQ in the U.S.
Exelixis announced the commercial availability of COMETRIQ for the treatment of patients with progressive, metastatic medullary thyroid cancer. The U.S. FDA approved COMETRIQ on November 29, 2012. COMETRIQ is being distributed exclusively through Diplomat Specialty Pharmacy in the U.S.
News For EXEL From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
August 27, 2015
09:26 EDTEXELOn The Fly: Pre-market Movers
Subscribe for More Information
06:07 EDTEXELExelixis' cobimetinib granted first regulatory approval in Switzerland
Subscribe for More Information
August 24, 2015
08:32 EDTEXELExelixis granted FDA Breakthrough Therapy Designation for cabozantinib
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use